The Valley Desk

NCT05298423 · Interventional trial

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

Overall registry status Completed

Phase 3

Conditions Carcinoma, Non-Small-Cell Lung

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov